| Application no. and date | 01963254.6 (espacenet) (Federated) (European Patent Register), 20010905 | | Patent/reg. no. and date | DK/EP 1315723, 20050727 | | Publication date | 20030604 | | Priority no. and date | GB 0021865, 20000906 | | EP pub. no. and date |
EP 1315723 20030604 | | Effective date | | | Applicant/owner | SMITHKLINE BEECHAM PLC, 980 Great West Road
Brentford,
Middlesex TW8 9GS, GB | | Applicant ref. no. | P200500813 EP DK | | Inventor | MILLAN, Michael,
GlaxoSmithKline, Old Powder Mills,
Near Leigh
Tonbridge,
Kent TN11 9AN, GB,
CRAIG, Andrew Simon,
GlaxoSmithKline, Old Powder Mills,
Near Leigh
Tonbridge,
Kent TN11 9AN, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61P 3/00 (2006.01) , C07D 417/12 (2006.01) | | Title | Hydrochloridsaltet af 5[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dion | | Int. application no. | GB2001003991 | | Int. publication no. | WO2002020519 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
